Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Endeavor Biomedicines, Inc.

Endeavor Biomedicines, Inc.

Stage unknownSan Diego, CAendeavorbiomedicines.comBiotechnology
Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
1
Financing history
1 rounds
  1. Apr 22, 2024
    Form D equity offering · $133M (form d sold) · 32 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Endeavor Biomedicines, Inc. filed Form D: $132,583,908 sold of $132,583,908, Biotechnology”
Investors on record
1 edges
People
5 officers, 5 directors
Timeline
2
  1. Sep 16, 2026
    Endeavor Biomedicines, Inc. no longer listed on Omega Fund Management, LLC's portfolio page
    Removed from portfolio page Inference Venture organization websites (about, team, portfolio, thesis, news pages)
  2. May 3, 2024
    Endeavor Biomedicines, Inc. filed Form D: $132,583,908 sold of $132,583,908, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
15 observations
Every observation on this company